Korsana Biosciences, Inc. (KRSA) stock
KRSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30493% above fair value
$33.27+0.77 (+2.37%)
Close on Nov 18, 2026Market cap $155.75MP/E –Yield –
Korsana Biosciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Korsana Biosciences's revenue for the twelve months ending Jun 30, 2026 was $1.90M, down 12.6% year over year. For fiscal 2025 it was $2.07M, up 3.7% from the year before. The highest annual figure on record is $4.51M in fiscal 2019.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.07M | +3.7% |
| FY2024 | Dec 31, 2024 | $2.00M | – |
| FY2023 | Dec 31, 2023 | $0 | -100.0% |
| FY2022 | Dec 31, 2022 | $297.00K | -92.5% |
| FY2021 | Dec 31, 2021 | $3.94M | +71.7% |
| FY2020 | Dec 31, 2020 | $2.30M | -49.1% |
| FY2019 | Dec 31, 2019 | $4.51M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | -100.0% |
| Q1 FY2026 | Mar 31, 2026 | $0 | -100.0% |
| Q4 FY2025 | Dec 31, 2025 | $1.03M | -43.2% |
| Q3 FY2025 | Sep 30, 2025 | $875.00K | +351.0% |
| Q2 FY2025 | Jun 30, 2025 | $93.00K | – |
| Q1 FY2025 | Mar 31, 2025 | $81.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $1.81M | – |
| Q3 FY2024 | Sep 30, 2024 | $194.00K | – |
| Q2 FY2024 | Jun 30, 2024 | $0 | – |
| Q1 FY2024 | Mar 31, 2024 | $0 | – |
| Q4 FY2023 | Dec 31, 2023 | $0 | – |
| Q3 FY2023 | Sep 30, 2023 | $0 | – |
| Q2 FY2023 | Jun 30, 2023 | $0 | -100.0% |
| Q1 FY2023 | Mar 31, 2023 | $0 | -100.0% |
| Q4 FY2022 | Dec 31, 2022 | $0 | -100.0% |
| Q3 FY2022 | Sep 30, 2022 | $0 | -100.0% |
| Q2 FY2022 | Jun 30, 2022 | $306.00K | -89.8% |
| Q1 FY2022 | Mar 31, 2022 | $711.00K | +1046.8% |
| Q4 FY2021 | Dec 31, 2021 | $533.00K | +300.8% |
| Q3 FY2021 | Sep 30, 2021 | $348.00K | -13.0% |
| Q2 FY2021 | Jun 30, 2021 | $3.00M | +300.5% |
| Q1 FY2021 | Mar 31, 2021 | $62.00K | -93.9% |
| Q4 FY2020 | Dec 31, 2020 | $133.00K | -91.0% |
| Q3 FY2020 | Sep 30, 2020 | $400.00K | -71.4% |
| Q2 FY2020 | Jun 30, 2020 | $749.00K | -54.0% |
| Q1 FY2020 | Mar 31, 2020 | $1.01M | – |
| Q4 FY2019 | Dec 31, 2019 | $1.48M | – |
| Q3 FY2019 | Sep 30, 2019 | $1.40M | – |
| Q2 FY2019 | Jun 30, 2019 | $1.63M | – |
See a number that looks wrong?